CAMP - NASDAQ
CAMP4 Therapeutics Corporation
$4.24
+1.7%CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
At a Glance
Live SnapshotCAMP4 Therapeutics Corporation Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
CAMP4 Therapeutics Corporation Income Statement
CAMP • NASDAQ
| CAMP4 Therapeutics Corporation Income Statement | Dec 2025 | Dec 2024 | Nov 2023 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | Feb 2009 | Mar 2008 | Mar 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
3.5M | 652K | 350K | 0.0 | 295.8M | 308.6M | 366.1M | 363.8M | 365.9M | 351.1M | 280.7M | 250.6M | 235.9M | 180.6M | 138.7M | 114.3M | 112.1M | 98.4M | 140.9M | 222.3M | |
GROSS PROFIT | ||||||||||||||||||||
(1.6M) | (0.0) | (0.0) | (0.0) | (174M) | (186.2M) | (222.8M) | (216M) | (215M) | (207.8M) | (177.8M) | (163.2M) | (156M) | (123.7M) | (96.7M) | (84.8M) | (89.7M) | (60.2M) | (122.4M) | (172.9M) | |
1.9M | 652K | 350K | 0.0 | 121.9M | 122.4M | 143.3M | 147.8M | 150.9M | 143.4M | 103M | 87.4M | 79.9M | 56.9M | 42M | 29.6M | 22.4M | 38.1M | 18.5M | 49.4M | |
OPERATING INCOME | ||||||||||||||||||||
(53.9M) | (53.7M) | (52.2M) | (45M) | (134.8M) | (125.9M) | (160M) | (120.1M) | (142.9M) | (142M) | (74.9M) | (62.5M) | (61.6M) | (40.9M) | (34.6M) | (31.6M) | (32.4M) | (38.4M) | (119M) | (71.5M) | |
(17.4M) | (14.9M) | (11.6M) | (10.2M) | (100.9M) | (95.3M) | (118.2M) | (81M) | (102.2M) | (104.9M) | (48.4M) | (36M) | (34.3M) | (24.9M) | (22M) | (19.4M) | (20.1M) | (21M) | (25.6M) | (22.5M) | |
(38.2M) | (38.8M) | (40.6M) | (34.8M) | (28.4M) | (25.8M) | (29.4M) | (27.7M) | (25.8M) | (22M) | (19.8M) | (19.9M) | (21.1M) | (14.3M) | (11.3M) | (11.1M) | (10.9M) | (12.9M) | (15.7M) | (15M) | |
-52.1M | -53.1M | -51.9M | -45M | -15.3M | -3.9M | -16.8M | 19.7M | 8M | 1.3M | 28.1M | 24.9M | 18.3M | 16M | 7.4M | -2.1M | -10M | -45M | -100.8M | -29M | |
PRE-TAX INCOME | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (6.3M) | (15.3M) | (15.5M) | (20.1M) | (16.7M) | (10.3M) | (9.9M) | (7.6M) | (72K) | (365K) | (487K) | (1.3M) | (1.4M) | (940K) | (1.1M) | (0.0) | (0.0) | |
2.2M | 1.3M | 2.8M | -6.3M | -15.3M | -15.5M | -20.1M | -16.7M | -10.3M | -9.9M | -7.6M | -72K | -365K | -487K | -1.3M | -1.4M | -940K | -911K | 0.0 | 0.0 | |
-1.6M | (0.0) | (0.0) | (0.0) | (5.4M) | (4.8M) | (12.3M) | -672K | (445K) | -101K | -20K | -68K | -67K | -45K | (1.3M) | (1.1M) | (1.4M) | (4.4M) | (77.7M) | (34M) | |
-28.3M | 1.3M | 2.6M | 809K | -14.7M | -16.7M | -41.6M | 12.9M | 31M | 1.6M | 1.9M | -140K | -67K | -45K | -830K | 50K | -2.2M | -44.7M | -72.2M | -35.7M | |
-80.4M | -51.8M | -49.3M | -44.2M | -30.1M | -20.6M | -58.3M | 23.9M | 28.7M | -7M | 22.3M | 24.8M | 17.9M | 15.4M | 5.3M | -3.5M | -12.2M | -45.9M | -103.3M | -28.4M | |
NET INCOME | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (1.1M) | (561K) | (20.5M) | -1.3M | (10.7M) | -1.1M | (4.6M) | (8.3M) | (6.1M) | -29.2M | (61K) | -172K | -1.4M | (3.8M) | -20.9M | (2.8M) | |
-80.4M | -51.8M | -49.3M | -44.2M | -31.1M | -21.2M | -78.8M | 18.4M | 16.6M | -7.2M | 16.9M | 16.5M | 11.8M | 44.6M | 5.2M | -3.3M | -10.9M | -49.7M | -84.1M | -31.2M |
SEC Filings
CAMP - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 24, 2026 | March 18, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 09, 2026 | January 09, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 23, 2025 | December 22, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 18, 2025 | December 17, 2025 | 2025 |
Related Guides
Continue your CAMP research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.